Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections

Kenneth A. Follett, Richard L. Boortz-Marx, James M. Drake, Stuart DuPen, Steven J. Schneider, Michael S. Turner, Robert J. Coffey

Research output: Contribution to journalReview article

122 Scopus citations

Abstract

Clinical study data and postmarket surveillance data on intrathecal drug delivery and spinal cord stimulation device infections were reviewed along with selected literature pertaining to cerebrospinal fluid shunt, implantable cardiac pacemaker, and surgical site infections. Most infections begin at the time of device implantation. Treatment typically involves antibiotic administration and device explantation. Available evidence suggests that the incidence of infection can be minimized by the use of published guidelines.

Original languageEnglish (US)
Pages (from-to)1582-1594
Number of pages13
JournalAnesthesiology
Volume100
Issue number6
DOIs
StatePublished - Jun 1 2004

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Fingerprint Dive into the research topics of 'Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections'. Together they form a unique fingerprint.

  • Cite this

    Follett, K. A., Boortz-Marx, R. L., Drake, J. M., DuPen, S., Schneider, S. J., Turner, M. S., & Coffey, R. J. (2004). Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections. Anesthesiology, 100(6), 1582-1594. https://doi.org/10.1097/00000542-200406000-00034